Silence Therapeutics plc (SLN) stock
SLNNasdaqPharmaceutical PreparationsAlso trades as SLNCF
$19.83+0.03 (+0.15%)
Close on Nov 13, 2026Market cap $936.90MP/E –Yield –
Silence Therapeutics profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Silence Therapeutics's profit margin for the twelve months ending Sep 30, 2026 was -11276.5%. For fiscal 2025 it was -15851.9%, against -104.7% the year before.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -15851.9% | −15747.1 |
| FY2024 | Dec 31, 2024 | -104.7% | +66.6 |
| FY2023 | Dec 31, 2023 | -171.4% | +61.1 |
| FY2022 | Dec 31, 2022 | -232.4% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q1 FY2026 | Mar 31, 2026 | -3544.3% | +16547.2 |
| Q4 FY2025 | Dec 31, 2025 | -34617.6% | −34666.3 |
| Q3 FY2025 | Sep 30, 2025 | -13181.1% | −10808.4 |
| Q2 FY2025 | Jun 30, 2025 | -12211.6% | −9598.5 |
| Q1 FY2025 | Mar 31, 2025 | -20091.5% | −20076.8 |
| Q4 FY2024 | Dec 31, 2024 | 48.6% | – |
| Q3 FY2024 | Sep 30, 2024 | -2372.8% | – |
| Q2 FY2024 | Jun 30, 2024 | -2613.1% | – |
| Q1 FY2024 | Mar 31, 2024 | -14.7% | – |
See a number that looks wrong?